Whole-body magnetic resonance imaging for cutaneous melanoma staging: A scientific review

doi:10.5306/wjco.v16.i8.109206

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-3)

Sum=2

Aug 24, 2025 (publication date) through Aug 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Clin Oncol. Aug 24, 2025; 16(8): 109206
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.109206

Whole-body magnetic resonance imaging for cutaneous melanoma staging: A scientific review

Anna Russo, Luca Marinelli, Vittorio Patanè, Marina Alessandrella, Maria Cristina Pezzella, Teresa Troiani, Gabriella Brancaccio, Camila Scharf, Giuseppe Argenziano, Salvatore Cappabianca, Alfonso Reginelli

Anna Russo, Luca Marinelli, Vittorio Patanè, Marina Alessandrella, Maria Cristina Pezzella, Teresa Troiani, Salvatore Cappabianca, Alfonso Reginelli, Department of Precision Medicine, University of Campania "L. Vanvitelli", Naples 80138, Campania, Italy

Gabriella Brancaccio, Camila Scharf, Giuseppe Argenziano, Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", Naples 80138, Campania, Italy

Author contributions: Reginelli A and Patanè V conceptualized the study; Marinelli L and Patanè V developed the methodology; Russo A and Alessandrella M performed the formal analysis; Patanè V and Marinelli L curated the data; Patanè V and Russo A prepared the original draft; Pezzella MC, Troiani T, Brancaccio G, and Scharf C reviewed and edited the manuscript; Argenziano G, Cappabianca S, and Reginelli A supervised the project. All authors have read and agreed to the published version of the manuscript.

Conflict-of-interest statement: Authors have no conflict of interest to disclose.

PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Vittorio Patanè, MD, Department of Precision Medicine, University of Campania "L. Vanvitelli", Piazza Luigi Miraglia 2, Naples 80138, Campania, Italy. vittorio.patane@unicampania.it

Received: May 7, 2025
Revised: May 19, 2025
Accepted: July 2, 2025
Published online: August 24, 2025
Processing time: 109 Days and 22.5 Hours

Core Tip

Core Tip: Whole body magnetic resonance imaging (MRI) is reshaping melanoma staging by providing high diagnostic accuracy without ionizing radiation. This review outlines how recent advances in diffusion imaging have enhanced lesion detection, particularly in bone, liver and brain while highlighting current limitations in pulmonary assessment and future directions such as hybrid positron emission tomography/MRI and molecular imaging for personalized oncology.